Keyphrases
Interleukin-2
100%
Autophagy
100%
Tumor Regression
100%
Chloroquine
100%
High-dose interleukin-2
60%
Liver
40%
Antitumor Effect
40%
High Mobility Group Box 1 (HMGB1)
40%
Renal Cell Carcinoma
20%
Apoptosis
20%
Tumor Growth
20%
Interleukin-6
20%
Tumor Cells
20%
Long-term Survival
20%
Hepatocytes
20%
Patients with Cancer
20%
Serum Levels
20%
Mitochondria
20%
Dose Effect
20%
Interleukin-18 (IL-18)
20%
Spleen
20%
Autophagic
20%
Melanoma Cells
20%
Oxidative Phosphorylation (OXPHOS)
20%
ATP Production
20%
Immune Infiltration
20%
Annexin V/propidium Iodide
20%
Cytochrome c Release
20%
Multiple Organ Dysfunction
20%
Autophagy Inhibitor
20%
Metastatic Liver Tumor
20%
Autophagic Vacuoles
20%
LC3-II
20%
Vascular Leakage
20%
Clinical Strategies
20%
Cleaved caspase-3
20%
Combined Administration
20%
Cleaved PARP
20%
Immunotherapy Efficacy
20%
Immune Cell Proliferation
20%
Decreased Toxicity
20%
Liver Tumor Model
20%
Mitochondrium
20%
Immunology and Microbiology
Immunotherapy
100%
Interleukin 2
100%
Autophagy
100%
Chloroquine
71%
Drug Megadose
42%
Cytokine
14%
Immunocompetent Cell
14%
Tumor Cell
14%
Cytosol
14%
Interleukin 6
14%
Blood Level
14%
Mitochondrion
14%
Propidium Iodide
14%
Interleukin 18
14%
Caspase
14%
Cell Proliferation
14%
Cell Infiltration
14%
Oxidative Phosphorylation
14%
Long Term Survival
14%
Programmed Cell Death
14%
Cytochrome
14%
Pharmacology, Toxicology and Pharmaceutical Science
Immunotherapy
100%
Interleukin 2
100%
Tumor Regression
100%
Chloroquine
71%
Neoplasm
14%
Tumor Growth
14%
Malignant Neoplasm
14%
Cytokine
14%
Renal Cell Carcinoma
14%
Adenosine Triphosphate
14%
Side Effect
14%
Syndrome
14%
Melanoma
14%
Caspase 3
14%
Interleukin 6
14%
Long Term Survival
14%
Tumor Model
14%
Lipocortin 5
14%
Cytochrome C
14%
Liver Tumor
14%
Propidium Iodide
14%
Interleukin 18
14%